NCT00469586 - Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes | Biotech Hunter

Enrollment

174

Participants

Timeline

Start Date

April 26, 2007

Primary Completion Date

April 24, 2008

Study Completion Date

April 24, 2008

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

inhaled human insulin

Treat-to-target dose titration scheme, pre-prandial, inhalation.

DRUG

metformin

Tablets, 2000 mg/day.

DRUG

glimepiride

Tablets, 4 mg/day.

DRUG

inhaled human insulin

Treat-to-target dose titration scheme, post-prandial, inhalation.

Trial Locations (59)

1130

Novo Nordisk Investigational Site, Vienna

1431

Novo Nordisk Investigational Site, Sofia

1606

Novo Nordisk Investigational Site, Sofia

2150

Novo Nordisk Investigational Site, Borsbeek

2483

Novo Nordisk Investigational Site, Ebreichsdorf

2820

Novo Nordisk Investigational Site, Bonheiden

3000

Novo Nordisk Investigational Site, Leuven

4500

Novo Nordisk Investigational Site, Huy

5020

Novo Nordisk Investigational Site, Salzburg

5500

Novo Nordisk Investigational Site, Mendoza

6700

Novo Nordisk Investigational Site, Arlon

9000

Novo Nordisk Investigational Site, Ghent

11108

Novo Nordisk Investigational Site, Narbonne

11650

Novo Nordisk Investigational Site, Mexico City

14000

Novo Nordisk Investigational Site, Mexico City

34093

Novo Nordisk Investigational Site, Istanbul

34371

Novo Nordisk Investigational Site, Istanbul

34718

Novo Nordisk Investigational Site, Istanbul

42001

Novo Nordisk Investigational Site, Konya

44093

Novo Nordisk Investigational Site, Nantes

44600

Novo Nordisk Investigational Site, Guadalajara

58033

Novo Nordisk Investigational Site, Nevers

58100

Novo Nordisk Investigational Site, Holon

59100

Novo Nordisk Investigational Site, Roubaix

64460

Novo Nordisk Investigational Site, Monterrey

75877

Novo Nordisk Investigational Site, Paris

84101

Novo Nordisk Investigational Site, Beersheba

91106

Novo Nordisk Investigational Site, Corbeil-Essonnes

91120

Novo Nordisk Investigational Site, Jerusalem

452010

Novo Nordisk Investigational Site, Indore

560041

Novo Nordisk Investigational Site, Bangalore

600034

Novo Nordisk Investigational Site, Hyderabad

641002

Novo Nordisk Investigational Site, Coimbatore

B1636DSU

Novo Nordisk Investigational Site, Buenos Aires

C1425AGC

Novo Nordisk Investigational Site, Buenos Aires

B7600FZN

Novo Nordisk Investigational Site, Mar del Plata

A 2421

Novo Nordisk Investigational Site, Kittsee

A 1160

Novo Nordisk Investigational Site, Vienna

T5J 3N4

Novo Nordisk Investigational Site, Edmonton

R3E 3P4

Novo Nordisk Investigational Site, Winnipeg

B3H 2Y9

Novo Nordisk Investigational Site, Halifax

L8L 2X2

Novo Nordisk Investigational Site, Hamilton

K7A 4W8

Novo Nordisk Investigational Site, Smiths Falls

H7T 2P5

Novo Nordisk Investigational Site, Laval

J1H 5N4

Novo Nordisk Investigational Site, Sherbrooke

L5M 2V8

Novo Nordisk Investigational Site, Mississauga

L1J 2K1

Novo Nordisk Investigational Site, Oshawa

S7N 0W8

Novo Nordisk Investigational Site, Saskatoon

G8T 7A1

Novo Nordisk Investigational Site, Trois-Rivières

695 032

Novo Nordisk Investigational Site, Thriruvananthapuram

03100

Novo Nordisk Investigational Site, Mexico City

80-858

Novo Nordisk Investigational Site, Gdansk

90-030

Novo Nordisk Investigational Site, Lodz

20-044

Novo Nordisk Investigational Site, Lublin

20-538

Novo Nordisk Investigational Site, Lublin

09-400

Novo Nordisk Investigational Site, Mazowieckie

96-200

Novo Nordisk Investigational Site, Rawa Mazowiecka

02-097

Novo Nordisk Investigational Site, Warsaw

41-800

Novo Nordisk Investigational Site, Zabrze